Cited by 804Immune Response and InflammationTuberculosis Research and EpidemiologyImmune responses and vaccinations

Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis

Open access
Means, Terry K, Wang, Shuyan, Lien, Egil, Yoshimura, Atsutoshi, Golenbock, Douglas T, Fenton, Matthew J·1999·The Journal of Immunology

Abstract

Recent studies have implicated a family of mammalian Toll-like receptors (TLR) in the activation of macrophages by Gram-negative and Gram-positive bacterial products. We have previously shown that different TLR proteins mediate cellular activation by the distinct CD14 ligands Gram-negative bacterial LPS and mycobacterial glycolipid lipoarabinomannan (LAM). Here we show that viable Mycobacterium tuberculosis bacilli activated both Chinese hamster ovary cells and murine macrophages that overexpressed either TLR2 or TLR4. This contrasted with Gram-positive bacteria and Mycobacterium avium, which activated cells via TLR2 but not TLR4. Both virulent and attenuated strains of M. tuberculosis could activate the cells in a TLR-dependent manner. Neither membrane-bound nor soluble CD14 was required for bacilli to activate cells in a TLR-dependent manner. We also assessed whether LAM was the mycobacterial cell wall component responsible for TLR-dependent cellular activation by M. tuberculosis. We found that TLR2, but not TLR4, could confer responsiveness to LAM isolated from rapidly growing mycobacteria. In contrast, LAM isolated from M. tuberculosis or Mycobacterium bovis bacillus Calmette-Guérin failed to induce TLR-dependent activation. Lastly, both soluble and cell wall-associated mycobacterial factors were capable of mediating activation via distinct TLR proteins. A soluble heat-stable and protease-resistant factor was found to mediate TLR2-dependent activation, whereas a heat-sensitive cell-associated mycobacterial factor mediated TLR4-dependent activation. Together, our data demonstrate that Toll-like receptors can mediate cellular activation by M. tuberculosis via CD14-independent ligands that are distinct from the mycobacterial cell wall glycolipid LAM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.163.7.3920

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Strohmeiher, G., and M. J. Fenton. 1999. Role of lipoarabinomannan in myco- bacterial pathogenesis and immunity. Microbes Inf. 2:1.Author: please confirm journal title; not in our sources.

Cited by

Sorted by citations

Authors
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J.
Affiliations
  • Boston University (US)
  • Boston Medical Center (US)
Corresponding author
Wang, Shuyan
Venue
The Journal of Immunology
Published
1999-10-01
Volume
163
Issue
7
Pages
3920-3927
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2102578857
Cited by
804
References
35
Citations by year
2026: 7 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 9 · 2018: 17 · 2017: 17 · 2016: 16 · 2015: 25 · 2014: 33 · 2013: 37 · 2012: 37
FWCI
19.04
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Kreftforeningen
  • Norges Forskningsråd
  • National Institutes of Health (5r01hl055681-05, GM54060)
  • National Heart, Lung, and Blood Institute (HL55681)
  • National Institute of General Medical Sciences (GM 54060)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
Toll-like receptors, Mycobacterium tuberculosis, TLR2, TLR4, lipoarabinomannan, macrophage activation, heat-stable factor, BCG, Mycobacterium avium, bacterial virulence
MeSH terms
Lipopolysaccharide-Binding Protein, Acute-Phase Proteins, Animals, Bacterial Proteins, Carrier Proteins, Cell Line, Fibroblasts, Cricetinae, Humans, Lipopolysaccharides, Macrophage Activation, Mannans, Membrane Glycoproteins, Mycobacterium tuberculosis, Receptors, Cell Surface, Solubility, CHO Cells, Lipopolysaccharide Receptors, Drosophila Proteins, Toll-Like Receptors, Toll-Like Receptor 2, Toll-Like Receptor 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review